FDA issued a Warning Letter to Texas Applied Biomedical Services on 9/24/2012 as a result of this inspection.
483 Texas Applied Biotechnology Research Review Committee Apr 2012

483 Texas Applied Biotechnology Research Review Committee Apr 2012

Jodi Gatica FDA$119.00 - Available Now

FDA investigators audited the Texas Applied Biotechnology Research Review Committee - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 25 Apr 2012.

Product details

  • Category: Biologics
  • Inspection end: 25 Apr 2012
  • Location: Houston, United States
  • FEI: 3003008014
Add To Cart